Sanofi Receives EC Approval for VaxRabeo Rabies Vaccine Across All Age Groups
Sanofi receives European Commission approval for VaxRabeo, a rabies vaccine for all age groups, offering pre- and post-exposure protection, comparable immune responses, improved thermostability and a five-year shelf life.
Imovax Rabies | 20/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy